Condition

T2DM (Type 2 Diabetes Mellitus) clinical trials and research

• 8Clinical trials
• 4Countries

Newest T2DM (Type 2 Diabetes Mellitus) clinical trials

All recruiting trials (8)

• Anti-inflammatory Diet for Type 2 Diabetes

  This study tests whether an anti-inflammatory diet can lower inflammation and improve blood sugar control in adults with type 2 diabetes.

  Recruiting Anhui Medical University · Hefei, Anhui · NCT07656805

• Chiglitazar added to SGLT-2 inhibitors for type 2 diabetes

  This real-world registry tests whether adding chiglitazar to ongoing SGLT-2 inhibitor therapy helps adults with type 2 diabetes improve blood sugar control and supports heart, kidney, and liver safety.

  Recruiting at 2 sites Chipscreen Biosciences, Ltd. · Beijing, Beijing Municipality and 1 other locations · NCT07580638

• Pulsendo for Type 2 Diabetes and fatty liver disease in adults

  This study tests the pulsENDO procedure in adults with type 2 diabetes who still have high blood sugar despite meds, to see if it helps their diabetes and fatty liver disease.

  Recruiting Chinese University of Hong Kong · Shatin · NCT07390422

• Semaglutide's effects on inflammation and blood vessel health in type 2 diabetes

  This trial will test whether adding semaglutide to standard treatment reduces inflammation and improves blood vessel function in adults with type 2 diabetes who do not have diagnosed heart disease.

  Recruiting at 2 sites Phase 4 Federico II University · Caserta, Caserta and 1 other locations · NCT07314684

• Chiglitazar for MASH and Type 2 Diabetes

  This trial tests whether chiglitazar can help adults with MASH and type 2 diabetes when added to standard vitamins and liver-supporting therapy.

  Recruiting Phase 2 Shanghai Jiao Tong University School of Medicine · Beijing, Beijing Municipality and 16 other locations · NCT07303803

• Metformin plus SGLT‑2 inhibitor and GLP‑1 receptor agonist triple therapy for poorly controlled type 2 diabetes

  This trial will see if adding an SGLT‑2 inhibitor and a GLP‑1 receptor agonist to metformin improves blood sugar control in adults with type 2 diabetes who have poor glycemic control.

  Recruiting Phase 4 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Tianjin, Tianjin Municipality · NCT07244003

• Assessing ezefeno for patients with dyslipidemia and type 2 diabetes

  This study is testing if a new combination treatment called ezefeno can help people with high cholesterol and type 2 diabetes lower their cholesterol levels and reduce heart risks when other medications aren't enough.

  Recruiting Korea University Anam Hospital · Seoul · NCT06293417

• Comparing Beinaglutide and Insulin for New Type 2 Diabetes Patients

  This study is testing whether a new treatment called Beinaglutide works better than insulin for adults who have just been diagnosed with type 2 diabetes.

  Recruiting at 16 sites Beijing Hospital · Beijing, Beijing Municipality and 15 other locations · NCT03987308

Related topics

Quick answers

How many T2DM (Type 2 Diabetes Mellitus) clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (5 trials), South Korea (1 trial), Italy (1 trial), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →